Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients

被引：0
|
作者：
Takaya Uno
Kyoichi Wada
Sachi Matsuda
Yuka Terada
Akira Oita
Atsushi Kawase
Mitsutaka Takada
机构：
[1] National Cerebral and Cardiovascular Center,Department of Pharmacy
[2] Kindai University,Division of Clinical Drug Informatics, Faculty of Pharmacy
[3] Kindai University,Department of Pharmacy, Faculty of Pharmacy
[4] Kindai University Graduate School of Pharmacy,Division of Cardiovascular Drugs, Therapy
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2018年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：665 / 673
页数：8
相关论文
共 50 条
  • [1] Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients
    Uno, Takaya
    Wada, Kyoichi
    Matsuda, Sachi
    Terada, Yuka
    Oita, Akira
    Kawase, Atsushi
    Takada, Mitsutaka
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (06) : 665 - 673
  • [2] Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects
    Suzuki, Yoshiharu
    Homma, Masato
    Doki, Kosuke
    Itagaki, Fumio
    Kohda, Yukinao
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (01) : 154 - 155
  • [3] Impact of CYP3A5 gene polymorphism on tacrolimus pharmacokinetics in kidney transplant patients in Kazakh population
    Madadov, Islam
    Baimakhanov, Bolatbek
    Yernur, Belgibayev
    Nabiyev, Elshad
    Saduakas, Nursultan
    Rgebayev, Berik
    Bolysbayeva, Farida
    Bayzhan, Aruzhan
    Kali, Altynai
    TRANSPLANTATION, 2024, 108 (09) : 370 - 370
  • [4] Impact of CYP3A5 gene polymorphism on tacrolimus pharmacokinetics in kidney transplant patients in Kazakh population
    Madadov, Islam
    Baimakhanov, Bolatbek
    Yernur, Belgibayev
    Nabiyev, Elshad
    Saduakas, Nursultan
    Rgebayev, Berik
    Bolysbayeva, Farida
    Bayzhan, Aruzhan
    Kali, Altynai
    TRANSPLANTATION, 2024, 108 (9S)
  • [5] Impact of CYP3A5 genotype on tacrolimus management in adult heart transplant recipients
    Pasternak, Amy
    Hong, Je-Won
    Lewis, Sarah
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 35 - 36
  • [6] CYP3A5 pharmacogenetic testing for tacrolimus in pediatric heart transplant patients: a budget impact analysis
    Wang, Jiaqi
    Pasternak, Amy L.
    Maggo, Simran
    Mindanao, Rochelle
    Nguyen, Jenny Q.
    Gong, Cynthia L.
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (02): : 81 - 86
  • [7] Impact of POR*28 Variant on Tacrolimus Pharmacokinetics in Kidney Transplant Patients with Different CYP3A5 Genotypes
    Everton, Janaina B. F.
    Patricio, Fernando J. B.
    Faria, Manuel S.
    Ferreira, Teresa C. A.
    Filho, Natalino Salgado
    Silva, Gyl E. B.
    Romao, Elen A.
    Magalhaes, Marcelo
    CURRENT DRUG METABOLISM, 2022, 23 (03) : 233 - 241
  • [8] Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose
    Bergmann, Troels K.
    Hennig, Stefanie
    Barraclough, Katherine A.
    Isbel, Nicole M.
    Staatz, Christine E.
    THERAPEUTIC DRUG MONITORING, 2014, 36 (01) : 62 - 70
  • [9] Impact of donor CYP3A5 genotype on pharmacokinetics of tacrolimus in South African paediatric liver transplant patients
    Wheeler, C.
    Masimirembwa, C.
    Mthembu, B.
    Botha, J.
    Scholefield, J.
    Fabian, J.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2024, 114 (3B): : 70 - 78
  • [10] Impact of the CYP3A4*1G Polymorphism and Its Combination with CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Japanese Renal Transplant Recipients
    Satoh, S.
    Miura, M.
    Kagaya, H.
    Saito, M.
    Numakura, K.
    Tsuchiya, N.
    Habuchi, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 83 - 83
12345